Laser technologies in treatment of arterial pathology

Abstract

INTRODUCTION: Cardiovascular diseases hold a leading position in the structure of mortality in the world. Laser technologies permit to improve the outcomes of endovascular and surgical treatment of various forms of the coronary heart disease and diseases of peripheral arteries. Despite the development of technologies, laser angioplasty and endarterectomy are associated with a number of complications and often require additional intervention.

AIM: To analyze currently available data on the use of lasers in treatment of arterial pathology.

According to the results of analysis of the modern literature, the use of lasers confidently occupies its niche in endovascular treatment of acute coronary syndrome, chronic occlusions of the coronary and peripheral arteries, permits to optimize the results of stenting and balloon angioplasty. One main disadvantage of laser angioplasty is that in most cases the procedure combines with stenting and/or balloon angioplasty and requires more contrast agent and longer operation time. Large-scale studies on the open laser endarterectomy have not been conducted.

CONCLUSION: Further study of the effect of laser on an atherosclerotic plaque and vessel wall in the open endarterectomy is a promising trend that may probably reduce the incidence of perioperative complications and improve long-term results of surgical treatment of diseases of peripheral arteries.

Keywords

laser surgery / laser angioplasty / laser endarterectomy / excimer laser

References

[1] McGuff PE, Bushnell D, Soroff HS, et al. Studies of the surgical applications of laser (light amplification by stimulated emission of radiation). Surg Forum. 1963;14:143–5.

[2] McGuff P.E., Bushnell D., Soroff H.S., et al. Studies of the surgical applications of laser (light amplification by stimulated emission of radiation) // Surg. Forum. 1963. Vol. 14. P. 143–145.

[3] Chatelain P, Meier B, de la Serna F, et al. Success with coronary angioplasty as seen at demonstrations of procedure. Lancet. 1992; 340(8829):1202–5. doi: 10.1016/0140-6736(92)92900-z

[4] Chatelain P., Meier B., de la Serna F., et al. Success with coronary angioplasty as seen at demonstrations of procedure // Lancet. 1992. Vol. 340, No. 8829. P. 1202–1205. doi: 10.1016/0140-6736(92)92900-z

[5] McQuillan C, Farag M, Egred M. Excimer Laser Coronary Angioplasty: Clinical Applications and Procedural Outcome, in a large–volume tertiary centre. Cardiology. 2021;146(2):137–43. doi: 10.1159/000513142

[6] McQuillan C., Farag M., Egred M. Excimer Laser Coronary Angioplasty: Clinical Applications and Procedural Outcome, in a Large–Volume Tertiary Centre // Cardiology. 2021. Vol. 146, No. 2. P. 137–143. doi: 10.1159/000513142

[7] Karacsonyi J, Armstrong EJ, Truong HTD, et al. Contemporary Use of Laser During Percutaneous Coronary Interventions: Insights from the Laser Veterans Affairs (LAVA) Multicenter Registry. J Invasive Cardiol. 2018;30(6):195–201.

[8] Karacsonyi J., Armstrong E.J., Truong H.T.D., et al. Contemporary Use of Laser During Percutaneous Coronary Interventions: Insights from the Laser Veterans Affairs (LAVA) Multicenter Registry // J. Invasive Cardiol. 2018. Vol. 30, No. 6. P. 195–201.

[9] Deckelbaum LI, Isner JM, Donaldson RF, et al. Reduction of laser-induced pathologic tissue injury using pulsed energy delivery. Am J Cardiol. 1985;56(10):662–7. doi: 10.1016/0002-9149(85)91031-8

[10] Deckelbaum L.I., Isner J.M., Donaldson R.F., et al. Reduction of laser–induced pathologic tissue injury using pulsed energy delivery // Am. J. Cardiol. 1985. Vol. 56, No. 10. P. 662–667. doi: 10.1016/0002-9149(85)91031-8

[11] Faria D, Jeronimo A, Escaned J, et al. Subacute right coronary artery thrombosis treated by using Excimer Laser Coronary Angioplasty: a case report. Eur Heart J Case Rep. 2023;7(10):ytad499. doi: 10.1093/ehjcr/ytad499

[12] Faria D., Jeronimo A., Escaned J., et al. Subacute right coronary artery thrombosis treated by using Excimer Laser Coronary Angioplasty: a case report // Eur. Heart J. Case Rep. 2023. Vol. 7, No. 10. P. ytad499. doi: 10.1093/ehjcr/ytad499

[13] Shevchenko YL, Ermakov DY, Maslennikov MA, et al. Tactics of Endovascular Treatment of Patients with Coronary Heart Disease with Recurrent Coronary In-Stent Restenosis Using Second- and Third-Generation Stent Systems and Paclitaxel-Coated Balloon Catheters. I. P. Pavlov Russian Medical Biological Herald. 2024; 32(1):5–16. (In Russ). doi: 10.17816/PAVLOVJ625996

[14] Шевченко Ю.Л., Ермаков Д.Ю., Масленников М.А., и др. Тактика эндоваскулярного лечения больных ишемической болезнью сердца с рецидивом внутристентового рестеноза коронарных артерий с использованием стент-систем второго и третьего поколения и покрытых паклитакселем баллонных катетеров // Россий-ский медико-биологический вестник имени академика И. П. Павлова. 2024. Т. 32, № 1. C. 5–16. doi: 10.17816/PAVLOVJ625996

[15] Kirtane AJ, Doshi D, Leon MB, et al. Treatment of Higher–Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention. Circulation. 2016;134(5):422–31. doi: 10.1161/circulationaha.116.022061

[16] Kirtane A.J., Doshi D., Leon M.B., et al. Treatment of Higher– Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention // Circulation. 2016. Vol. 134, No. 5. P. 422–431. doi: 10.1161/circulationaha.116.022061

[17] Topaz O, Bernardo NL, Shah R, et al. Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris. Am J Cardiol. 2001;87(7):849–55. doi: 10.1016/s0002-9149(00)01525-3

[18] Topaz O., Bernardo N.L., Shah R., et al. Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris // Am. J. Cardiol. 2001. Vol. 87, No. 7. P. 849–855. doi: 10.1016/s0002-9149(00)01525-3

[19] Nishino M, Mori N, Takiuchi S, et al. Indications and outcomes of excimer laser coronary atherectomy: Efficacy and safety for thrombotic lesions — The ULTRAMAN registry. J Cardiol. 2017;69(1): 314–9. doi: 10.1016/j.jjcc.2016.05.018

[20] Nishino M., Mori N., Takiuchi S., et al. Indications and outcomes of excimer laser coronary atherectomy: Efficacy and safety for thrombotic lesions — The ULTRAMAN registry // J. Cardiol. 2017. Vol. 69, No. 1. P. 314–319. doi: 10.1016/j.jjcc.2016.05.018

[21] Shibata N, Takagi K, Morishima I, et al. The impact of the excimer laser on myocardial salvage in ST-elevation acute myocardial infarction via nuclear scintigraphy. Int J Cardiovasc Imaging. 2020;36(1):161–70. doi: 10.1007/s10554-019-01690-x

[22] Shibata N., Takagi K., Morishima I., et al. The impact of the excimer laser on myocardial salvage in ST-elevation acute myocardial infarction via nuclear scintigraphy // Int. J. Cardiovasc. Imaging. 2020. Vol. 36, No. 1. P. 161–170. doi: 10.1007/s10554-019-01690-x

[23] Topaz O, Ebersole D, Das T, et al. Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter study). Am J Cardiol. 2004;93(6):694–701. doi: 10.1016/j.amjcard.2003.11.050

[24] Topaz O., Ebersole D., Das T., et al. Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter study) // Am. J. Cardiol. 2004. Vol. 93, No. 6. P. 694–701. doi: 10.1016/j.amjcard.2003.11.050

[25] Dörr M, Vogelgesang D, Hummel A, et al. Excimer laser thrombus elimination for prevention of distal embolization and no-reflow in patients with acute ST elevation myocardial infarction: results from the randomized LaserAMI study. Int J Cardiol. 2007;116(1):20–6. doi: 10.1016/j.ijcard.2006.03.024

[26] Dörr M., Vogelgesang D., Hummel A., et al. Excimer laser thrombus elimination for prevention of distal embolization and no-reflow in patients with acute ST elevation myocardial infarction: results from the randomized LaserAMI study // Int. J. Cardiol. 2007. Vol. 116, No. 1. P. 20–26. doi: 10.1016/j.ijcard.2006.03.024

[27] Kujiraoka H, Tsuchiyama T, Inagaki D, et al. Comparison of the efficacy of excimer laser coronary angioplasty for ST-segment elevation myocardial infarction with onset-to-balloon time. Lasers Med Sci. 2023;38(1):126. doi: 10.1007/s10103-023-03789-z

[28] Kujiraoka H., Tsuchiyama T., Inagaki D., et al. Comparison of the efficacy of excimer laser coronary angioplasty for ST-segment elevation myocardial infarction with onset-to-balloon time // Lasers Med. Sci. 2023. Vol. 38, No. 1. P. 126. doi: 10.1007/s10103-023-03789-z

[29] Shimojo K, Shibata N, Takagi K, et al. Excimer laser coronary angioplasty versus manual aspiration thrombectomy in patients with ST-segment elevation myocardial infarction: analyzed by nuclear scintigraphy. Int J Cardiovasc Imaging. 2023;39(4):831–42. doi: 10.1007/s10554-022-02771-0

[30] Shimojo K., Shibata N., Takagi K., et al. Excimer laser coronary angioplasty versus manual aspiration thrombectomy in patients with ST-segment elevation myocardial infarction: analyzed by nuclear scintigraphy // Int. J. Cardiovasc. Imaging. 2023. Vol. 39, No. 4. P. 831–842. doi: 10.1007/s10554-022-02771-0

[31] Nicolais C, Lakhter V, Virk HUH, et al. Therapeutic Options for In-Stent Restenosis. Curr Cardiol Rep. 2018;20(2):7. doi: 10.1007/s11886-018-0952-4

[32] Nicolais C., Lakhter V., Virk H.U.H., et al. Therapeutic Options for In-Stent Restenosis // Curr. Cardiol. Rep. 2018. Vol. 20, No. 2. P. 7. doi: 10.1007/s11886-018-0952-4

[33] Hirose S, Ashikaga T, Hatano Y, et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty: benefits over scoring balloon angioplasty alone. Lasers Med Sci. 2016;31(8): 1691–6. doi: 10.1007/s10103-016-2039-z

[34] Hirose S., Ashikaga T., Hatano Y., et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty: benefits over scoring balloon angioplasty alone // Lasers Med. Sci. 2016. Vol. 31, No. 8. P. 1691–1696. doi: 10.1007/s10103-016-2039-z

[35] Sethi A, Malhotra G, Singh S, et al. Efficacy of various percutaneous interventions for in-stent restenosis: comprehensive network meta-analysis of randomized controlled trials. Circ Cardiovasc Interv. 2015;8(11):e002778. doi: 10.1161/circinterventions. 115.002778

[36] Sethi A., Malhotra G., Singh S., et al. Efficacy of various percutaneous interventions for in-stent restenosis: comprehensive network meta-analysis of randomized controlled trials // Circ. Cardiovasc. Interv. 2015. Vol. 8, No. 11. P. e002778. doi: 10.1161/circinterventions.115.002778

[37] Hajibandeh S, Hajibandeh S, Antoniou SA, et al. Treatment strategies for in-stent restenosis in peripheral arterial disease: a systematic review. Interact Cardiovasc Thorac Surg. 2019;28(2):253–61. doi: 10.1093/icvts/ivy233

[38] Hajibandeh S., Hajibandeh S., Antoniou S.A., et al. Treatment strategies for in-stent restenosis in peripheral arterial disease: a systematic review // Interact. Cardiovasc. Thorac. Surg. 2019. Vol. 28, No. 2. P. 253–261. doi: 10.1093/icvts/ivy233

[39] Hibui T, Tsuchiyama T, Masuda S, et al. Excimer laser coronary atherectomy prior to paclitaxel-coated balloon angioplasty for de novo coronary artery lesions. Lasers Med Sci. 2021;36(1):111–7. doi: 10.1007/s10103-020-03019-w

[40] Hibui T., Tsuchiyama T., Masuda S., et al. Excimer laser coronary atherectomy prior to paclitaxel–coated balloon angioplasty for de novo coronary artery lesions // Lasers Med. Sci. 2021. Vol. 36, No. 1. P. 111–117. doi: 10.1007/s10103-020-03019-w

[41] Pereira GTR, Dallan LAP, Vergara–Martel A, et al. Treatment of In-Stent Restenosis Using Excimer Laser Coronary Atherectomy and Bioresorbable Vascular Scaffold Guided by Optical Coherence Tomography. Cardiovasc Revasc Med. 2021;22:44–9. doi: 10.1016/j.carrev.2020.05.006

[42] Pereira G.T.R., Dallan L.A.P., Vergara–Martel A., et al. Treatment of In-Stent Restenosis Using Excimer Laser Coronary Atherectomy and Bioresorbable Vascular Scaffold Guided by Optical Coherence Tomography // Cardiovasc. Revasc. Med. 2021. Vol. 22. P. 44–49. doi: 10.1016/j.carrev.2020.05.006

[43] Topaz O, Das T, Dahm J, et al. Excimer laser revascularisation: current indications, applications and techniques. Lasers Med Sci. 2001;16(2):72–7. doi: 10.1007/pl00011345

[44] Topaz O., Das T., Dahm J., et al. Excimer laser revascularisation: current indications, applications and techniques // Lasers Med. Sci. 2001. Vol. 16, No. 2. P. 72–77. doi: 10.1007/pl00011345

[45] Mangieri A, Jabbour RJ, Tanaka A, et al. Excimer laser facilitated coronary angioplasty of a heavy calcified lesion treated with bioresorbable scaffolds. J Cardiovasc Med (Hagerstown). 2016;17 (suppl 2):e149–50. doi: 10.2459/jcm.0000000000000397

[46] Mangieri A., Jabbour R.J., Tanaka A., et al. Excimer laser facilitated coronary angioplasty of a heavy calcified lesion treated with bioresorbable scaffolds // J. Cardiovasc. Med. (Hagers-town). 2016. Vol. 17, Suppl. 2. P. e149–e150. doi: 10.2459/jcm.0000000000000397

[47] Fernandez JP, Hobson AR, McKenzie D, et al. Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions. EuroIntervention. 2013;9(2):243–50. doi: 10.4244/eijv9i2a40

[48] Fernandez J.P., Hobson A.R., McKenzie D., et al. Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions // EuroIntervention. 2013. Vol. 9, No. 2. P. 243–250. doi: 10.4244/eijv9i2a40

[49] Karacsonyi J, Alaswad K, Choi JW, et al. Laser for balloon uncrossable and undilatable chronic total occlusion interventions. Int J Cardiol. 2021;336:33–7. doi: 10.1016/j.ijcard.2021.05.015

[50] Karacsonyi J., Alaswad K., Choi, J.W., et al. Laser for balloon uncrossable and undilatable chronic total occlusion interventions // Int. J. Cardiol. 2021. Vol. 336. P. 33–37. doi: 10.1016/j.ijcard.2021.05.015

[51] Nan J, Joseph TA, Bell MR, et al. Outcomes of excimer laser-contrast angioplasty for stent underexpansion. EuroIntervention. 2021;17(1):78–80. doi: 10.4244/eij-d-19-01074

[52] Nan J., Joseph T.A., Bell M.R., et al. Outcomes of excimer laser-contrast angioplasty for stent underexpansion // EuroIntervention. 2021. Vol. 17, No. 1. P. 78–80. doi: 10.4244/eij-d-19-01074

[53] Knoraracsonyi J, Danek BA, Karatasakis A, et al. Laser Coronary Atherectomy During Contrast Injection for Treating an Under-expanded Stent. JACC Cardiovasc Interv. 2016;9(15):e147–8. doi: 10.1016/j.jcin.2016.04.040

[54] Karacsonyi J., Danek B.A., Karatasakis A., et al. Laser Coronary Atherectomy During Contrast Injection for Treating an Under-expanded Stent // JACC Cardiovasc. Interv. 2016. Vol. 9, No. 15. P. e147–e148. doi: 10.1016/j.jcin.2016.04.040

[55] Lee T, Shlofmitz RA, Song L, et al. The effectiveness of excimer laser angioplasty to treat coronary in-stent restenosis with peri-stent calcium as assessed by optical coherence tomography. EuroIntervention. 2019;15(3):e279–88. doi: 10.4244/eij-d-18-00139

[56] Lee T., Shlofmitz R.A., Song L., et al. The effectiveness of excimer laser angioplasty to treat coronary in-stent restenosis with peri-stent calcium as assessed by optical coherence tomography // EuroIntervention. 2019. Vol. 15, No. 3. P. e279–e288. doi: 10.4244/eij-d-18-00139

[57] Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(1, Suppl S):S5A–67A. doi: 10.1016/j.jvs.2006.12.037

[58] Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-Society Consensus for Management of Peripheral Arterial Disease (TASC II) // J. Vasc. Surg. 2007. Vol. 45, No. 1, Suppl. S. P. S5A–S67A. doi: 10.1016/j.jvs.2006.12.037

[59] Neville RF, Sidawy AN. Myointimal hyperplasia: basic science and clinical considerations. Semin Vasc Surg. 1998;11(3):142–8.

[60] Neville R.F., Sidawy A.N. Myointimal hyperplasia: basic science and clinical considerations // Semin. Vasc. Surg. 1998. Vol. 11, No. 3. P. 142–148.

[61] Shammas NW, Aasen N, Bailey L, et al. Two Blades-Up Runs Using the JetStream Navitus Atherectomy Device Achieve Optimal Tissue Debulking of Nonocclusive In-Stent Restenosis: Observations From a Porcine Stent/Balloon Injury Model. J Endovasc Ther. 2015; 22(4):518–24. doi: 10.1177/1526602815592135

[62] Shammas N.W., Aasen N., Bailey L., et al. Two Blades-Up Runs Using the JetStream Navitus Atherectomy Device Achieve Optimal Tissue Debulking of Nonocclusive In-Stent Restenosis: Observations From a Porcine Stent/Balloon Injury Model // J. Endovasc. Ther. 2015. Vol. 22, No. 4. P. 518–524. doi: 10.1177/1526602815592135

[63] Dippel EJ, Makam P, Kovach R, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv. 2015;8(1, Pt A):92–101. doi: 10.1016/j.jcin.2014.09.009

[64] Dippel E.J., Makam P., Kovach R., et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) // JACC Cardiovasc. Interv. 2015. Vol. 8, No. 1, Pt. A. P. 92–101. doi: 10.1016/j.jcin.2014.09.009

[65] Laird JR Jr, Yeo KK, Rocha–Singh K, et al. Excimer laser with adjunctive balloon angioplasty and heparin–coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve–month results from the SALVAGE study. Catheter Cardiovasc Interv. 2012;80(5):852–9. doi: 10.1002/ccd.23475

[66] Laird J.R. Jr, Yeo K.K., Rocha–Singh K., et al. Excimer laser with adjunctive balloon angioplasty and heparin–coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve–month results from the SALVAGE study // Catheter. Cardiovasc. Interv. 2012. Vol. 80, No. 5. P. 852–859. doi: 10.1002/ccd.23475

[67] Scheinert D, Laird JR, Schröder M, et al. Excimer laser–assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther. 2001;8(2):156–66. doi: 10.1177/152660280100800210

[68] Scheinert D., Laird J.R., Schröder M., et al. Excimer laser–assisted recanalization of long, chronic superficial femoral artery occlusions // J. Endovasc. Ther. 2001. Vol. 8, No. 2. P. 156–166. doi: 10.1177/152660280100800210

[69] Steinkamp HJ, Rademaker J, Wissgott C, et al. Percutaneous transluminal laser angioplasty versus balloon dilation for treatment of popliteal artery occlusions. J Endovasc Ther. 2002;9(6):882–8. doi: 10.1177/152660280200900623

[70] Steinkamp H.J., Rademaker J., Wissgott C., et al. Percutaneous transluminal laser angioplasty versus balloon dilation for treatment of popliteal artery occlusions // J. Endovasc. Ther. 2002. Vol. 9, No. 6. P. 882–888. doi: 10.1177/152660280200900623

[71] Dave RM, Patlola R, Kollmeyer K, et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther. 2009;16(6):665–75. doi: 10.1583/09-2781.1

[72] Dave R.M., Patlola R., Kollmeyer K., et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry // J. Endovasc. Ther. 2009. Vol. 16, No. 6. P. 665–675. doi: 10.1583/09-2781.1

[73] Laird JR, Zeller T, Gray BH, et al. Limb salvage following laser–assisted angioplasty for critical limb ischemia: results of the LACI multi-center trial. J Endovasc Ther. 2006;13(1):1–11. doi: 10.1583/05-1674.1

[74] Laird J.R., Zeller T., Gray B.H., et al. Limb salvage following laser–assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial // J. Endovasc. Ther. 2006. Vol. 13, No. 1. P. 1–11. doi: 10.1583/05-1674.1

[75] Bosiers M, Peeters P, Elst FV, et al. Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study. Eur J Vasc Endovasc Surg. 2005;29(6):613–9. doi: 10.1016/j.ejvs.2005.01.008

[76] Bosiers M., Peeters P., Elst F.V., et al. Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study // Eur. J. Vasc. Endovasc. Surg. 2005. Vol. 29, No. 6. P. 613–619. doi: 10.1016/j.ejvs.2005.01.008

[77] Yang Y–P, Lin T–H, Chou C–Y, et al. Effect of Limb Salvage by Excimer Laser Angioplasty Plus Low-Pressure Balloon Inflation in Chronic Limb-Threatening Ischemia Patients with Infrapopliteal Vessel Disease. Acta Cardiol Sin. 2023;39(5):765–72. doi: 10.6515/acs.202309_39(5).20230115a

[78] Yang Y.–P., Lin T.–H., Chou C.–Y., et al. Effect of Limb Salvage by Excimer Laser Angioplasty Plus Low-Pressure Balloon Inflation in Chronic Limb-Threatening Ischemia Patients with Infrapopliteal Vessel Disease // Acta Cardiol. Sin. 2023. Vol. 39, No. 5. P. 765–772. doi: 10.6515/acs.202309_39(5).20230115a

[79] Jayet J, Coscas R, Heim F, et al. Laser uses in non-coronary arterial disease. An Vasc Surg. 2019;57:229–37. doi: 10.1016/j.avsg.2018.06.010

[80] Jayet J., Coscas R., Heim F., et al. Laser uses in non-coronary arterial disease // An. Vasc. Surg. 2019. Vol. 57. P. 229–237. doi: 10.1016/j.avsg.2018.06.010

[81] Serino F, Cao Y, Renzi C, et al. Excimer laser ablation in the treatment of total chronic obstructions in critical limb ischaemia in diabetic patients. Sustained efficacy of plaque recanalisation in mid-term results. Eur J Vasc Endovasc Surg. 2010;39(2):234–8. doi: 10.1016/j.ejvs.2009.10.018

[82] Serino F., Cao Y., Renzi C., et al. Excimer laser ablation in the treatment of total chronic obstructions in critical limb ischaemia in diabetic patients. Sustained efficacy of plaque recanalisation in mid-term results // Eur. J. Vasc. Endovasc. Surg. 2010. Vol. 39, No. 2. P. 234–238. doi: 10.1016/j.ejvs.2009.10.018

[83] Eugene J, McColgan SJ, Hammer–Wilson M, et al. Laser endarterectomy. Lasers Surg Med. 1985;5(3):265–74. doi: 10.1002/lsm.1900050308

[84] Eugene J., McColgan S.J., Hammer–Wilson M., et al. Laser endarterectomy // Lasers Surg. Med. 1985. Vol. 5, No. 3. P. 265–274. doi: 10.1002/lsm.1900050308

[85] Eugene J, Ott RA, Nudelman KL, et al. Initial clinical evaluation of carotid artery laser endarterectomy. J Vasc Surg. 1990;12(4):499–503.

[86] Eugene J., Ott R.A., Nudelman K.L., et al. Initial clinical evaluation of carotid artery laser endarterectomy // J. Vasc. Surg. 1990. Vol. 12, No. 4. P. 499–503.

[87] Eugene J, Ott RA, Baribeau Y, et al. Initial trial of argon ion laser endarterectomy for peripheral vascular disease. Arch Surg. 1990;125(8):1007–10. doi: 10.1001/archsurg.1990.01410200071010

[88] Eugene J., Ott R.A., Baribeau Y., et al. Initial trial of argon ion laser endarterectomy for peripheral vascular disease // Arch. Surg. 1990. Vol. 125, No. 8. P. 1007–1010. doi: 10.1001/archsurg.1990. 01410200071010

RIGHTS & PERMISSIONS

Staroverov IN, Il’in MV, Tikhov AV, Churakov SO, Lonchakova OM, Dzhavoyan MF